Clontech, Tet Expand Licensing Agreement | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Clontech Laboratories and Tet Systems said today they have expanded an existing licensing agreement to grant Clontech rights to develop, manufacture, and commercialize novel Tet products, including the Tet-On 3G Inducible Expression System.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.